financetom
Business
financetom
/
Business
/
Ferrari Settles 3.625% Notes Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ferrari Settles 3.625% Notes Offering
May 21, 2024 7:31 AM

10:07 AM EDT, 05/21/2024 (MT Newswires) -- Ferrari ( RACE ) said Tuesday it has settled its offering of 500 million euros ($542.7 million) of 3.625% notes due Tuesday with an issue price of 99.677%.

The net proceeds from the offering, after covering the offering costs and related expenses, were approximately 497 million euros.

Shares of Ferrari ( RACE ) were down 0.5% in recent Tuesday trading.

Price: 414.54, Change: -2.11, Percent Change: -0.51

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KALA BIO Says Will Cease Development of Drug Candidate, Eyes Layoffs After Failed Trial
KALA BIO Says Will Cease Development of Drug Candidate, Eyes Layoffs After Failed Trial
Sep 29, 2025
08:51 AM EDT, 09/29/2025 (MT Newswires) -- KALA BIO ( KALA ) said Monday that it will cease development of its drug candidate KPI-012 as a potential treatment for persistent corneal epithelial defect after it failed to meet its primary endpoint of complete healing in a phase 2b clinical trial. KPI-012 also failed to achieve statistical significance for key secondary...
Abbott Says Health Canada Approves Dissolving Stent for Treating Blocked Arteries Below the Knee
Abbott Says Health Canada Approves Dissolving Stent for Treating Blocked Arteries Below the Knee
Sep 29, 2025
08:52 AM EDT, 09/29/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Monday that Health Canada has approved the company's Esprit BTK Everolimus Eluting Resorbable Scaffold System for treating people with chronic limb-threatening ischemia below the knee. The system is designed to keep arteries open while delivering the drug everolimus to support vessel healing before completely dissolving, the company...
Novartis to Launch US Direct-to-Patient Platform for Cosentyx
Novartis to Launch US Direct-to-Patient Platform for Cosentyx
Sep 29, 2025
08:50 AM EDT, 09/29/2025 (MT Newswires) -- Novartis ( NVS ) said Monday it plans to launch a direct-to-patient platform for Cosentyx in the US, effective Nov. 1. The company said the platform will give cash-paying patients the option to buy Cosentyx, a treatment for multiple immune-mediated inflammatory diseases, at a 55% discount off the list price. Novartis ( NVS...
Stellantis has cut 10,000 Italy jobs in four years, union reports
Stellantis has cut 10,000 Italy jobs in four years, union reports
Sep 29, 2025
MILAN (Reuters) -Stellantis ( STLA ) has slashed nearly 10,000 jobs in Italy in the past four years, while vehicle production, including vans and small trucks, more than halved since 2004, the Fiom-Cgil union reported on Monday. Stellantis ( STLA ) includes Italian brands Fiat, Lancia and Alfa Romeo, which significantly shrank their operations in recent years while the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved